» Articles » PMID: 36588364

Radiomics Signature for Prediction of Long-term Survival and Recurrence Patterns in Patients with Gastric Cancer After Radical Gastrectomy: A Multicenter Study

Overview
Specialty Gastroenterology
Date 2023 Jan 2
PMID 36588364
Authors
Affiliations
Soon will be listed here.
Abstract

Background: This study aimed to develop and validate a radiomics score to predict the long-term survival and patterns of recurrence of gastric cancer (GC).

Methods: A total of 513 patients who underwent radical gastrectomy for GC after curative resection between 2008 and 2016 at two institutions were analyzed. A radiomics score was generated using the least absolute shrinkage and selection operator Cox regression model on 327 patients and was validated in 186 patients. A nomogram consisting of the radiomics score and clinicopathological factors was created and compared with the tumor-lymph node-metastasis (TNM) staging system. Model performance was assessed using calibration, discrimination, and clinical usefulness.

Results: The radiomics score was established based on five selected features. A higher score was significantly associated with poorer recurrence-free survival (RFS) and overall survival (OS) rates, both in the training and validation cohorts (P < 0.05). Multivariate analysis demonstrated that the radiomics score was an independent prognostic factor for both RFS and OS (P < 0.05). A nomogram incorporating the radiomics score had a significantly better prognostic value than the TNM system alone. Moreover, a high score was significantly associated with an increased risk of distant recurrence, a medium score was significantly associated with an increased risk of peritoneal recurrence, and a low score was significantly associated with an increased risk of locoregional recurrence, in the entire cohort (P < 0.05).

Conclusions: The newly proposed radiomics score may be a powerful predictor of long-term outcomes and recurrence patterns of GC. Further studies are warranted to confirm these findings.

Citing Articles

Clinical utility of multi-row spiral CT in diagnosing hepatic nodular lesions, gastric cancer, and Crohn's disease: a comprehensive meta-analysis.

Xu M, Chen Y, Liu D, Wang L, Wu M Am J Clin Exp Immunol. 2024; 13(4):165-176.

PMID: 39310125 PMC: 11411159. DOI: 10.62347/SREJ4505.


Ultrasound radiomics signature for predicting central lymph node metastasis in clinically node-negative papillary thyroid microcarcinoma.

Liu J, Yu J, Wei Y, Li W, Lu J, Chen Y Thyroid Res. 2024; 17(1):4.

PMID: 38369523 PMC: 10875890. DOI: 10.1186/s13044-024-00191-x.

References
1.
Ma Z, Fang M, Huang Y, He L, Chen X, Liang C . CT-based radiomics signature for differentiating Borrmann type IV gastric cancer from primary gastric lymphoma. Eur J Radiol. 2017; 91:142-147. DOI: 10.1016/j.ejrad.2017.04.007. View

2.
. Japanese gastric cancer treatment guidelines 2014 (ver. 4). Gastric Cancer. 2016; 20(1):1-19. PMC: 5215069. DOI: 10.1007/s10120-016-0622-4. View

3.
Gillies R, Kinahan P, Hricak H . Radiomics: Images Are More than Pictures, They Are Data. Radiology. 2015; 278(2):563-77. PMC: 4734157. DOI: 10.1148/radiol.2015151169. View

4.
Razzak M . Genetics: new molecular classification of gastric adenocarcinoma proposed by The Cancer Genome Atlas. Nat Rev Clin Oncol. 2014; 11(9):499. DOI: 10.1038/nrclinonc.2014.138. View

5.
Kim J, Lee H, Seo H, Jung Y, Park C . Stage-specific difference in timing and pattern of initial recurrence after curative surgery for gastric cancer. Surg Oncol. 2019; 30:81-86. DOI: 10.1016/j.suronc.2019.05.023. View